Skip to Content

Join the 'Glaucoma with Pupillary Block' group to help and get support from people like you.

Glaucoma with Pupillary Block News

Generic Eye Drops for Seniors Could Save Millions of Dollars a Year

Posted 28 Jul 2017 by Drugs.com

FRIDAY, July 28, 2017 – Prescribing generic drugs for seniors' eye problems could save the U.S. government hundreds of millions of dollars a year, a new study suggests. Conditions like glaucoma and dry eye that require daily eye drops are common in old age. University of Michigan researchers report that eye doctors caring for seniors prescribe brand-name medications in more than three-quarters of cases, compared to one-third of cases among nearly all other specialties. "Lawmakers are currently looking for ways to reduce federal spending for health care, and policies that favor generics over brand medications or allow Medicare to negotiate drug prices may lead to cost savings," said study senior author Lindsey De Lott, of the university's Kellogg Eye Center. "Using a brand medication for a single patient may not seem like a big deal, but ultimately, these higher costs are paid by all of ... Read more

Related support groups: Eye Conditions, Glaucoma, Eye Dryness/Redness, Cataract, Glaucoma (Open Angle), Lumigan, Latanoprost, Xalatan, Travatan, Alphagan, Combigan, Travatan Z, Systane, Azopt, Cosopt, Dorzolamide, Soothe, Dry Eye Disease, Refresh, Brimonidine

Health Tip: Applying Eye Drops

Posted 9 May 2017 by Drugs.com

-- Applying eye drops without the excess trickling down your face can be tricky. The American Academy of Allergy Asthma and Immunology suggests: Wash your hands, then take the bottle of eye drops and slowly rotate it for 30 seconds. Lean your head back and gently pull down the lower eyelid. Use your index finger to pull down the lid, or use your thumb and index finger to gently pinch the lower lid. Taking care to avoid the dropper touching your eye, let one drop fall into the pocket formed in your lower eyelid. If you are supposed to use more than one drop, wait three to four minutes before applying the second one. Close your eyes for a minute, then put gentle pressure over the spot where your eyelid joins with your nose. Replace the cap on the bottle. Use a tissue to wipe away any extra medicine, and wash your hands again. Read more

Related support groups: Eye Conditions, Glaucoma, Eye Dryness/Redness, Cataract, Glaucoma (Open Angle), Conjunctivitis, Conjunctivitis - Bacterial, Dry Eye Disease, Glaucoma/Intraocular Hypertension, Conjunctivitis - Allergic, Seasonal Allergic Conjunctivitis, Inclusion Conjunctivitis, Glaucoma (Narrow Angle), Ocular Fungal Infection, Neonatal Conjunctivitis, Glaucoma with Pupillary Block

U.S. Glaucoma Cases Expected to Surge by 2030

Posted 6 Jan 2017 by Drugs.com

FRIDAY, Jan. 6, 2017 – Glaucoma affects more than 3 million Americans, but that number is expected to surge to more than 4 million by 2030, eye experts say. Glaucoma is a group of incurable eye diseases that gradually lead to vision loss. There are two main types of glaucoma, but the most common form, which typically affects older people, causes an increase in pressure inside the eye that damages the optic nerve, according to the Glaucoma Research Foundation. Glaucoma is the No. 1 cause of preventable blindness, but the condition often develops without warning, the foundation said. Medication or surgery can help slow or prevent vision loss, but many people with glaucoma aren't even aware they have it. In many cases, the condition isn't detected until people lose side – or peripheral – vision. Eventually, glaucoma may cause people to permanently lose up to 40 percent of their vision, ... Read more

Related support groups: Diabetes, Type 2, Glaucoma, Diabetes, Type 1, Glaucoma (Open Angle), Pre-Diabetes, Diabetes Mellitus, Glaucoma/Intraocular Hypertension, Abnormal Glucose Tolerance, Glaucoma (Narrow Angle), Visual Defect/Disturbance, Glaucoma with Pupillary Block

Contacts May One Day Be Used to Deliver Glaucoma Medication

Posted 30 Aug 2016 by Drugs.com

TUESDAY, Aug. 30, 2016 – A special type of contact lens has been designed to gradually deliver medication to the eye, researchers report. This kind of contact lens could help people who have a hard time using eye drops to treat conditions such as glaucoma, the study authors explained. The new study showed that the drug-dispensing lenses were able to effectively lower the eye pressure in monkeys with glaucoma at least as much as the standard eye drops used to treat the disease. "This promising delivery system removes the burden of administration from the patient and ensures consistent delivery of medication to the eye, eliminating the ongoing concern of patient compliance with dosing," study co-author Dr. Janet Serle said in a news release from the Massachusetts Eye and Ear Infirmary. Serle is a glaucoma specialist at Icahn School of Medicine at Mount Sinai in New York City. Glaucoma is ... Read more

Related support groups: Eye Conditions, Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Blindness Biggest Fear for Many Americans

Posted 4 Aug 2016 by Drugs.com

THURSDAY, Aug. 4, 2016 – Blindness is what many Americans fear most, a new survey shows. "These findings underscore the importance of good eyesight to most and that having good vision is key to one's overall sense of well-being," said lead researcher Dr. Adrienne Scott and colleagues. Scott is an assistant professor of opthalmology at Johns Hopkins University School of Medicine in Baltimore. "The consistency of these findings among the varying ethnic/racial groups underscores the importance of educating the public on eye health and mobilizing public support for vision research," the researchers added in a news release. The nationwide online poll, commissioned by the nonprofit health research group known as Research!America, found that 88 percent of more than 2,000 respondents considered good vision vital to overall health. And 47 percent said losing their sight would have the most ... Read more

Related support groups: Eye Conditions, Smoking, Smoking Cessation, Glaucoma, Cataract, Glaucoma (Open Angle), Macular Degeneration, Retinal Disorders, Visual Defect/Disturbance, Glaucoma (Narrow Angle), Refraction - Assessment, Color Vision Defect (Acquired), Glaucoma with Pupillary Block

Routine Eye Exams See Vision Problems You Miss

Posted 14 Jul 2016 by Drugs.com

WEDNESDAY, July 13, 2016 – Routine eye checkups often pick up unnoticed problems, particularly in older adults, a new study says. "In asymptomatic patients, comprehensive routine optometric eye examinations detect a significant number of new eye conditions and/or results in management changes," said the study's author, Elizabeth Irving, and her colleagues from the University of Waterloo in Ontario, Canada. More than half of people with no new symptoms or vision problems receive new prescriptions or treatment changes as a result of routine eye exams, the researchers found. The need for vision prescription changes was found for two out of five people, the study noted. Meanwhile, 16 percent were diagnosed with a new eye condition and 31 percent had a change in their ongoing care, researchers found. The study included data on nearly 6,400 patients who visited a university eye clinic over ... Read more

Related support groups: Eye Conditions, Glaucoma, Cataract, Glaucoma (Open Angle), Macular Degeneration, Uveitis, Iritis, Keratitis, Optic Nerve Disorder, Ocular Herpes Simplex, Retinal Disorders, Macular Edema, Corneal Ulcer, Corneal Abrasion, Glaucoma/Intraocular Hypertension, Diagnosis and Investigation, Chorioretinitis, Strabismus, Vitreomacular Adhesion, Glaucoma (Narrow Angle)

Could 'Zaps' to the Brain Help Fight Glaucoma?

Posted 3 Jul 2016 by Drugs.com

FRIDAY, July 1, 2016 – Electrical pulses to the brain may help restore vision in some partially blind patients, German researchers report. Glaucoma and other types of damage to the eye's optic nerve typically cause permanent damage. But, the new technique appears to kick-start the brain's visual control centers, the researchers explained. A 10-day treatment regimen – entailing upwards of nearly an hour a day of electrical pulses aimed directly into the eye – improved vision among patients who were losing their sight, the researchers said. "By giving currents through the eye, we force retinal cells connected to the brain to fire intensely," explained study author Dr. Bernhard Sabel, a member of the medical faculty at the Otto-von-Guericke University of Magdeburg. "This activates the brain's [vision] cells to function better again. And, 'what fires together, wires together.' " ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Diagnosis and Investigation, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

25 Million Americans Will Struggle With Vision Problems by 2050

Posted 19 May 2016 by Drugs.com

THURSDAY, May 19, 2016 – As baby boomers age, the number of Americans with vision problems and blindness is expected to double over the next three decades, a new study suggests. In 2015, slightly more than 12 million Americans had a vision problem. But by 2050, that number will rise to 25 million, the researchers predicted. "This study gives us a GPS for our nation's future eye health," said lead researcher Dr. Rohit Varma, a professor of ophthalmology at the University of Southern California Keck School of Medicine in Los Angeles. "Our group and others have shown in previous studies that those who suffer from vision loss not only have a decreased quality of life but can also experience both physical and mental health decline, including an increased risk for chronic health conditions such as diabetes, depression and even death," he said. The economic burden from vision loss and eye ... Read more

Related support groups: Glaucoma, Cataract, Glaucoma (Open Angle), Macular Degeneration, Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Visual Defect/Disturbance, Glaucoma with Pupillary Block, Aphakia, Pseudophakia

Health Tip: Putting Medicine in Your Eyes

Posted 16 Feb 2016 by Drugs.com

-- You may be wary about applying those new eyedrops prescribed by your doctor. The Cleveland Clinic recommends: Use warm water and soap to wash your hands, then dry with a clean towel. Either grab a mirror or lie down before applying the medicine. Look up at the ceiling, then use one hand to pull down the lower eyelid. Hold the medicine in your other hand, resting on your forehead if needed. Without letting the tip of the bottle or tube touch the eye, gently place the medicine inside your lower eyelid. Then close your eye. If you are taking both an ointment and an eye drop, put the eye drop in first. Wait about five minutes before applying the ointment. Read more

Related support groups: Eye Conditions, Glaucoma, Eye Dryness/Redness, Glaucoma (Open Angle), Macular Degeneration, Conjunctivitis, Conjunctivitis - Bacterial, Blepharitis, Keratitis, Corneal Ulcer, Corneal Abrasion, Ocular Herpes Simplex, Glaucoma/Intraocular Hypertension, Eye Redness/Itching, Conjunctivitis - Allergic, Seasonal Allergic Conjunctivitis, Blepharoconjunctivitis, Glaucoma (Narrow Angle), Herpes Simplex Dendritic Keratitis, Glaucoma with Pupillary Block

Green, Leafy Vegetables Each Day May Help Keep Glaucoma at Bay

Posted 14 Jan 2016 by Drugs.com

THURSDAY, Jan. 14, 2016 – Eating green leafy vegetables daily may decrease the risk of glaucoma – a serious eye disease – by 20 percent or more over many years, a new study suggests. "We found those consuming the most green leafy vegetables had a 20 to 30 percent lower risk of glaucoma," said study leader Jae Kang. Kang is an assistant professor of medicine at Brigham and Women's Hospital and Harvard Medical School in Boston. Glaucoma is an eye condition that usually develops when fluid increases in the front part of the eye and causes pressure, damaging the optic nerve. It can lead to loss of vision, according to the U.S. National Eye Institute. Although the study found an association between eating more leafy greens and a lower risk of glaucoma, it didn't prove cause-and-effect. Kang's team followed nearly 64,000 participants in the Nurses' Health Study from 1984 through 2012, and ... Read more

Related support groups: Eye Conditions, Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Scientists Spot Three More Genes Linked to Glaucoma Risk

Posted 11 Jan 2016 by Drugs.com

MONDAY, Jan. 11, 2016 – The discovery of three more genes linked to the most common type of glaucoma could boost efforts to fight the eye disease, researchers report. The three newly identified genes associated with primary open angle glaucoma bring the total number of such genes to 15, according to the study published online Jan. 11 in Nature Genetics. "Just in time for Glaucoma Awareness Month (January), this unprecedented analysis provides the most comprehensive genetic profile of glaucoma to date," Dr. Paul Sieving, director of the U.S. National Eye Institute (NEI), said in an institute news release. "These findings open avenues for the pursuit of new strategies to screen for, prevent and treat glaucoma," he added. Glaucoma is the most common cause of irreversible vision loss, and it affects 60 million people worldwide and about 2.7 million Americans. The disease causes vision loss ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Mobius Therapeutics Receives Final FDA Approval for New Glaucoma Drug Mitosol

Posted 9 Feb 2012 by Drugs.com

ST. LOUIS, Feb. 9, 2012 /PRNewswire/ – Mobius Therapeutics, LLC, a St. Louis-based ophthalmic company, has received final approval from the U.S. Food and Drug Administration for the platform product, Mitosol. This initial indication is for the use of Mitosol in glaucoma surgery. With FDA approval, Mobius Therapeutics can start marketing and production efforts for Mitosol immediately. "The approval of Mitosol for use in glaucoma surgery represents the culmination of more than five years of work on the part of Mobius Therapeutics," said Ed Timm, President of Mobius Therapeutics. "It will provide surgeons, hospitals, and patients with enhanced convenience, safety, and consistency in the surgical treatment of glaucoma." Glaucoma is the second-leading cause of blindness in the United States. It is treated progressively, beginning with pharmaceuticals, then office intervention and finally ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Ophthalmic Surgery, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Spending on Glaucoma Meds Rising in U.S., Study Finds

Posted 13 Jun 2011 by Drugs.com

MONDAY, June 13 – Spending on medications for Americans with the eye disease glaucoma has increased overall and especially among certain groups of patients, a new study finds. Researchers analyzed data from 1,404 patients aged 18 and older who used glaucoma medication between 2001 and 2006. The average amount spent per patient for glaucoma medications increased from $445 in 2001 to $557 in 2006. Among the groups most likely to be associated with significant increases in spending on glaucoma medications were women, people who had only public health insurance and those who hadn't completed high school. Spending on glaucoma medications was higher among patients with Medicare Part D coverage than among those with private insurance, said Dr. Byron L. Lam, of the Bascom Palmer Eye Institute in Miami, and colleagues. Glaucoma is a leading cause of blindness in the United States. As the ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

New Contact Lenses Could Improve Glaucoma Treatment

Posted 24 Mar 2010 by Drugs.com

WEDNESDAY, March 24 – A team of researchers has created special contact lenses for glaucoma patients that come loaded with vitamin E, using a design that could essentially lengthen the amount of time a medication bathes an afflicted eye. This strategy could reduce the significant waste of medication that happens with traditional eye drops, but so far the concept has only been tested in beagles. "Currently, the way we deliver medication to the eye is very bad and very ineffective," said study author Anuj Chauhan, an associate professor in the department of chemical engineering at the University of Florida in Gainesville. "And this approach is wonderful because it delivers drugs for a long period of time." Chauhan and his colleagues are to present their findings Wednesday at the American Chemical Society annual meeting in San Francisco. According to the Glaucoma Research Foundation, ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Special Eye Drops May Reverse Glaucoma Damage

Posted 16 Dec 2009 by Drugs.com

TUESDAY, Aug. 4 – A new type of eye drop appears to protect retinal and optic nerve cells – and even reverse some sight loss – in patients battling glaucoma, a leading cause of blindness, new research suggests. Italian researchers found that the topical use of nerve growth factor, which is easily absorbed by the eye in drop form, spares retinal ganglion cells from nerve damage caused by the build-up of eye pressure associated with glaucoma. This is "the first evidence that nerve growth factor eye drops may represent a potential treatment for glaucoma," said Dr. Stefano Bonini, professor and chairman of the department of ophthalmology at the University of Rome Campus Bio-Medico. Bonini and his team reported their findings in the Aug. 3 online edition of the Proceedings of the National Academy of Sciences. Glaucoma is an often symptom-less grouping of incurable, but treatable, eye ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Ask a Question

Further Information

Related Condition Support Groups

Glaucoma